EcoDrugPlus

Tyrosine Hydroxylase

Ensembl ID : ENSSTUG00000004702
Gene Symbol: TH
3 Cross references
187 Possible Orthologues:

Tyrosine Kinase 2

Ensembl ID : ENSSTUG00000015939
Gene Symbol: TYK2
3 Cross references
190 Possible Orthologues:

Tyrosine Kinase 2

Ensembl ID : ENSSTUG00000007665
Gene Symbol: TYK2
3 Cross references
190 Possible Orthologues:

Tyrosine-Protein Kinase Fyn

Ensembl ID : ENSSTUG00000037621
Gene Symbol: LOC115194124
3 Cross references
153 Possible Orthologues:

Tyrosine-Protein Kinase Fyn-Like

Ensembl ID : ENSSTUG00000030751
Gene Symbol: LOC115190053
3 Cross references
189 Possible Orthologues:

Tyrosine-Protein Kinase Hck-Like

Ensembl ID : ENSSTUG00000035272
Gene Symbol: LOC115166008
2 Cross references
196 Possible Orthologues:

Tyrosine-Protein Kinase Jak1-Like

Ensembl ID : ENSSTUG00000014197
Gene Symbol: LOC115192234
3 Cross references
205 Possible Orthologues:

Tyrosine-Protein Kinase Jak2-Like

Ensembl ID : ENSSTUG00000004012
Gene Symbol: LOC115164747
3 Cross references
194 Possible Orthologues:

Tyrosine-Protein Kinase Jak2-Like

Ensembl ID : ENSSTUG00000011222
Gene Symbol: LOC115149432
3 Cross references
193 Possible Orthologues:

Tyrosine-Protein Kinase Jak2-Like

Ensembl ID : ENSSTUG00000004997
Gene Symbol: LOC115159121
3 Cross references
192 Possible Orthologues:

Tyrosine-Protein Kinase Lyn-Like

Ensembl ID : ENSSTUG00000012145
Gene Symbol: LOC115169751
3 Cross references
189 Possible Orthologues:

Tyrosine-Protein Kinase Lyn-Like

Ensembl ID : ENSSTUG00000043704
Gene Symbol: LOC115157025
3 Cross references
189 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).